Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in Progress
Shun Lü, Ignacio Casarini, Terufumi Kato, Manuel Cobo, Mustafa Özgüroğlu, Rachel Hodge, Toon van der Gronde, Matilde Saggese, Suresh S. Ramalingam
Topics & Concepts
MedicineOsimertinibInternal medicineLung cancerOncologyProgression-free survivalT790MAdverse effectResponse Evaluation Criteria in Solid TumorsClinical endpointClinical trialCancerPhases of clinical researchEpidermal growth factor receptorErlotinibGefitinibChemotherapyLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research Studies